ERG and prostate cancer: Somatic mutations in prostate cancer-driver genes play a significant role in tumorigenesis and development, and mutations in over 97 genes have been identified that act as cancer driver genes, including mutations for TMPRSS2-ERG, TP53, and PTEN 12.